Amedeo Smart

Free Medical Literature Service

 

Amedeo

Stem Cell Research
  Free Subscription

Articles published in
Leuk Lymphoma
    August 2025
  1. CHUMNUMSIRIWATH P, Vittayawacharin P, Pinter-Brown L, Brem EA, et al
    Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma.
    Leuk Lymphoma. 2025 Aug 21:1-5. doi: 10.1080/10428194.2025.2547985.
    >> Share

  2. TOLU SS, Gribbin C, Chen Z, Seshadri MR, et al
    Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents.
    Leuk Lymphoma. 2025 Aug 14:1-11. doi: 10.1080/10428194.2025.2540437.
    >> Share

  3. GO AE, Feliciano EJG, Ho FDV, Dee EC, et al
    Hematopoietic stem cell Transplants in the Philippines: barriers to accessibility.
    Leuk Lymphoma. 2025 Aug 9:1-3. doi: 10.1080/10428194.2025.2544076.
    >> Share

    July 2025
  4. ANDREADIS C, Bobek O, Hsi ED, Fenske TS, et al
    Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup doub
    Leuk Lymphoma. 2025 Jul 9:1-10. doi: 10.1080/10428194.2025.2525982.
    >> Share

  5. ODSTRCIL BOBILLO MS, McClune B, Couriel DR
    Access barriers to hematopoietic stem cell transplantation and CAR T-cells in US.
    Leuk Lymphoma. 2025 Jul 6:1-11. doi: 10.1080/10428194.2025.2513003.
    >> Share

  6. GULLAKSEN SE, Omsland M, Brevik M, Letzner J, et al
    CML stem cells and their interactions and adaptations to tyrosine kinase inhibitors.
    Leuk Lymphoma. 2025;66:1211-1220.
    >> Share

    June 2025
  7. KOYABU S, Onaka T, Imada K
    Ponatinib may make allogeneic hematopoietic stem cell transplantation unnecessary for CML-BC under specific conditions, such as de novo cases: a case series of de novo CML-BC treated with ponatinib and no transplantation.
    Leuk Lymphoma. 2025 Jun 25:1-4. doi: 10.1080/10428194.2025.2521646.
    >> Share

  8. RATHJE K, Kroger N
    Optimal timing of allogeneic hematopoietic stem cell transplant in MDS.
    Leuk Lymphoma. 2025 Jun 19:1-13. doi: 10.1080/10428194.2025.2514662.
    >> Share

  9. MEIRELES AM, Oliveira Rodrigues Amarante ACD, Marques Catita BMC, Abilheira Monjardino MTPB, et al
    Effects of fludarabine dosage on transplant-related outcomes in hematopoietic stem cell transplantation.
    Leuk Lymphoma. 2025 Jun 11:1-5. doi: 10.1080/10428194.2025.2509701.
    >> Share

    May 2025
  10. THORDARDOTTIR TH, Rodenbach RA, Brauer M, Hall AC, et al
    'A perfect match': how hematologists discuss donor options and risks with black and white patients considering allogeneic stem cell transplant.
    Leuk Lymphoma. 2025 May 7:1-10. doi: 10.1080/10428194.2025.2500625.
    >> Share

  11. RAMACHANDRA N, Vegivinti CTR, Sahu S, Sanawar R, et al
    Transforming growth factor beta receptor type I (TGF-betaRI) kinase inhibitors IOA-359 and IOA-360 stimulate erythropoiesis in MDS.
    Leuk Lymphoma. 2025;66:920-929.
    >> Share

    April 2025
  12. GOSHO K, Sadato D, Kato S, Toya T, et al
    Diamond-Blackfan anemia syndrome in an adult with RPS19 and DDX41 variants successfully treated with allogeneic stem cell transplantation: a case report.
    Leuk Lymphoma. 2025 Apr 2:1-4. doi: 10.1080/10428194.2025.2486432.
    >> Share

    March 2025
  13. BISCHOF L, Ussmann J, Platzbecker U, Jentzsch M, et al
    Allogeneic stem cell transplantation for MDS-clinical issues, choosing preparative regimens and outcome.
    Leuk Lymphoma. 2025 Mar 12:1-14. doi: 10.1080/10428194.2025.2476652.
    >> Share

  14. TUCCI A, Re A, Pagani C, Marcheselli L, et al
    A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study.
    Leuk Lymphoma. 2025 Mar 8:1-9. doi: 10.1080/10428194.2025.2471499.
    >> Share

    February 2025
  15. SUN Y, Liu N, Liu Y, Deng J, et al
    Isolated CNS B lymphoid/myeloid bilineage relapse following allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with KMT2A::MLLT1 rearrangement.
    Leuk Lymphoma. 2025 Feb 10:1-4. doi: 10.1080/10428194.2025.2460046.
    >> Share

    December 2024
  16. SHUMILOV E, Levien L, Mazzeo P, Jung W, et al
    Allogeneic stem cell transplantation against aggressive lymphomas: graft-versus-lymphoma effects in peripheral T-cell lymphoma and diffuse large B-cell lymphoma after myeloablative conditioning.
    Leuk Lymphoma. 2024 Dec 11:1-12. doi: 10.1080/10428194.2024.2438805.
    >> Share

  17. PAISIOU A, OIkonomopoulou C, Pavlidis D, Ampatzidou M, et al
    CDKN2A/B deletion as an independent negative prognostic factor for allogeneic hematopoietic stem cell transplantation in childhood B cell precursor acute lymphoblastic leukemia.
    Leuk Lymphoma. 2024 Dec 1:1-4. doi: 10.1080/10428194.2024.2434177.
    >> Share

    November 2024
  18. LECORNEC N, Duchmann M, Itzykson R
    Single-cell sequencing applications in acute myeloid leukemia.
    Leuk Lymphoma. 2024 Nov 4:1-15. doi: 10.1080/10428194.2024.2422833.
    >> Share

    October 2024
  19. DEHGHANI SS, Wang Y, Ramesh KH, Cooper D, et al
    Atypical chronic myeloid leukemia (CML) with ETV6-ABL1 mutation managed successfully with a third-generation TKI and hematopoietic stem cell transplant.
    Leuk Lymphoma. 2024 Oct 18:1-3. doi: 10.1080/10428194.2024.2403666.
    >> Share

    August 2024
  20. JEANSELME P, Tavitian S, Lapierre L, Vergez F, et al
    Long-term exposure and response to azacitidine for post-hematopoietic stem cell transplantation relapse of early T-cell precursor acute lymphoblastic leukemia: a case report and review of the literature.
    Leuk Lymphoma. 2024 Aug 14:1-6. doi: 10.1080/10428194.2024.2390572.
    >> Share

    July 2024
  21. DALAL P, Dalal J
    PTCy-ATG mutually exclusive or additive? Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia.
    Leuk Lymphoma. 2024 Jul 31:1-2. doi: 10.1080/10428194.2024.2379976.
    >> Share

  22. TARANTINI F, Cumbo C, Anelli L, Zagaria A, et al
    Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?
    Leuk Lymphoma. 2024 Jul 23:1-12. doi: 10.1080/10428194.2024.2381649.
    >> Share

  23. HU M, Li J, Hu T, Zhang Z, et al
    Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia.
    Leuk Lymphoma. 2024 Jul 7:1-10. doi: 10.1080/10428194.2024.2376179.
    >> Share

  24. STEWART C, Owen C, Chua N, Peters A, et al
    Importance of long-term follow-up of autologous stem cell transplantation for mantle cell lymphoma.
    Leuk Lymphoma. 2024 Jul 5:1-4. doi: 10.1080/10428194.2024.2373323.
    >> Share

    June 2024
  25. JIANG J, Sigmund AM, Zhao Q, Elder P, et al
    Impact of chronic graft-versus-host disease on non-relapse mortality and survival.
    Leuk Lymphoma. 2024 Jun 12:1-8. doi: 10.1080/10428194.2024.2365910.
    >> Share

    May 2024
  26. NAGAYAMA T, Fujiwara SI, Tominaga R, Yokoyama D, et al
    Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation.
    Leuk Lymphoma. 2024 May 20:1-7. doi: 10.1080/10428194.2024.2352614.
    >> Share

  27. VON DEM BORNE PA, Kemps-Mols BM, de Wreede LC, van Beek AA, et al
    The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide.
    Leuk Lymphoma. 2024 May 6:1-11. doi: 10.1080/10428194.2024.2344060.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016